{
    "code": 0,
    "data": [
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Please find enclosed herewith news paper publication regarding special window for transfer and dematerialization of physical shares.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e63c53e1-932c-414b-9eb5-b7c3040afcf4.pdf",
            "news_date": "2026-02-10 15:26:56"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find enclosed herewith transcript of the earnings call held on February 04 2026.",
            "news_id": "0716d0a0-92d8-4e36-8f74-0b0eafb02747",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=180ea216-6a53-4636-ab60-29dd53fac631.pdf",
            "news_date": "2026-02-07 16:29:40",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find enclosed herewith transcript of the earnings call held on February 04 2026.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=180ea216-6a53-4636-ab60-29dd53fac631.pdf",
            "news_date": "2026-02-07 16:29:40"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Please find enclosed herewith audio recording of earnings call held on February 04 2026.",
            "news_id": "3ae747ad-348f-459e-bd0e-f745d098fbbd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fcea7cd5-3b2f-4b34-b2c9-8f7821638d4b.pdf",
            "news_date": "2026-02-04 18:30:56",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Please find enclosed herewith audio recording of earnings call held on February 04 2026.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fcea7cd5-3b2f-4b34-b2c9-8f7821638d4b.pdf",
            "news_date": "2026-02-04 18:30:56"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Please find enclosed herewith the copy of newspaper publication with respect to the unaudited financial results of the Company for the quarter and nine months ended December 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e8d8c752-56b0-4c92-b790-892b573c544f.pdf",
            "news_date": "2026-02-02 15:57:24"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Earnings Presentation for the quarter and nine months ended December 31 2025",
            "news_id": "774e001a-5cc7-45ba-a008-5e6576a07728",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5c354304-ec2f-4ebe-82ed-74a8a9f086c1.pdf",
            "news_date": "2026-01-31 15:12:19",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Earnings Presentation for the quarter and nine months ended December 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5c354304-ec2f-4ebe-82ed-74a8a9f086c1.pdf",
            "news_date": "2026-01-31 15:12:19"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Quarterly Earnings Release dated January 31 2026",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a9ddd515-f81c-441d-bccf-85cc97a1b61d.pdf",
            "news_date": "2026-01-31 15:07:13"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Update On The Judicial Proceedings Against Advanced Supplementary Technologies Corporation USA (Step Down Wholly Owned Subsidiary) [AST]",
            "news_body": "This has reference to our earlier intimation dated February 28 2024 regarding the lawsuit filed by World Nutrition Inc. against Advanced Supplementary Technologies Corporation USA a step-down wholly owned subsidiary of the Company before the District Court of Arizona (USA)",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5e177715-38ba-40f8-9618-95359ebde96b.pdf",
            "news_date": "2026-01-31 14:46:12"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "General_Announcements",
            "descriptor": "Acquisition",
            "caption": "Announcement under Regulation 30 (LODR)-Acquisition",
            "news_body": "Approved collaboration of the Company with a developer for setting up of a Group captive Wind Power Plant through a Special Purpose Vechile Company (SPV) and the Company along with other consumers if any to invest in upto 26% equity stake in the proposed SPV as a Captive User for the said electricity power.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f49e412a-5dae-4e55-9066-b475be8efb5e.pdf",
            "news_date": "2026-01-31 12:53:49"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results (Standalone & Consolidated) Of The Company For The Quarter And Nine Months Ended December 31 2025",
            "news_body": "Advanced Enzyme Technologies Limited has informed the Exchange about the Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter and nine months  ended December 31 2025",
            "news_id": "ec7c8d32-1612-4db8-99f7-f797caffdcd1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aaf65f4e-7c7e-46c8-93e6-b8ad49eb3969.pdf",
            "news_date": "2026-01-31 12:47:21",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Unaudited Financial Results (Standalone & Consolidated) Of The Company For The Quarter And Nine Months Ended December 31 2025",
            "news_body": "Advanced Enzyme Technologies Limited has informed the Exchange about the Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter and nine months  ended December 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aaf65f4e-7c7e-46c8-93e6-b8ad49eb3969.pdf",
            "news_date": "2026-01-31 12:47:21"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On January 31 2026",
            "news_body": "With reference to the notice of Board Meeting dated January 23 2026 we hereby inform that the Board of Directors at its Meeting held on January 31 2026 has inter-alia approved the following :\r\n1) Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter and nine months ended December 31 2025\r\n2) Collaboration of the Company with a developer for setting up of a Group Captive Wind Power Plant through a Special Purpose Vehicle company (SPV) and the Company along with other consumers if any to invest in up to 26% equity stake in the proposed SPV as a Captive User for the said electricity power",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2af3371c-bdaa-44cf-872b-fe26891f244e.pdf",
            "news_date": "2026-01-31 12:39:19"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform that the Company will host a Conference call for Analysts and Investors to discuss the Un-audited financial results of the Company for the quarter and nine months ended December 31 2025 on Wednesday February 04 2026 at 04:00 p.m. (IST)",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eda82c9c-5583-4c8d-9ef9-7b5a2ec5ffe8.pdf",
            "news_date": "2026-01-28 18:12:29"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Approval Of Un-Audited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Nine Months Ended December 31 2025.",
            "news_body": "Advanced Enzyme Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2026 inter alia to consider and approve Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter and nine months ended December 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=46b499b0-dee4-4fce-b512-383b22a1286c.pdf",
            "news_date": "2026-01-23 16:40:47"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Update - Intimation Regarding Conversion Of Statutory Auditors Firm From M S K A & Associates To M S K A & Associates LLP",
            "news_body": "Intimation regarding conversion of Statutory Audit Firm from    M S K A & Associates to M S K A & Associates LLP Chartered Accountants effectived from January 13 2026",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2e5953a0-ec72-4b1c-894f-64a08acdb9d9.pdf",
            "news_date": "2026-01-15 14:19:24"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Please find enclosed herewith compliance certificate under Regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended December 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=37756493-e1d0-4787-bf4f-83e0ad0ff251.pdf",
            "news_date": "2026-01-09 16:36:43"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Please find enclosed herewith intimation of closure of trading window from January 01 2026.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=205fc370-fa92-4eee-9d0c-56b9f90a47e1.pdf",
            "news_date": "2025-12-26 11:25:34"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find enclosed herewith transcript of the earnings conference call held on November 12 2025.",
            "news_id": "21d976fa-f0c2-4913-9b49-a8567c8612c6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=98f9af2e-9e6f-4756-89f4-1de7b2a1585d.pdf",
            "news_date": "2025-11-17 16:30:13",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find enclosed herewith transcript of the earnings conference call held on November 12 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=98f9af2e-9e6f-4756-89f4-1de7b2a1585d.pdf",
            "news_date": "2025-11-17 16:30:13"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Conference Call for the Un-audited Financial Results for the quarter and half year ended September 30 2025",
            "news_id": "2a838dc0-1443-4854-8969-ef8359edf3ca",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0cf7c856-3d15-451c-8433-40dd82060157.pdf",
            "news_date": "2025-11-13 18:44:46",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Conference Call for the Un-audited Financial Results for the quarter and half year ended September 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0cf7c856-3d15-451c-8433-40dd82060157.pdf",
            "news_date": "2025-11-13 18:44:46"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Please find enclosed herewith news paper publication with respect to the unaudited financial results for the quarter and half year ended September 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=96c837e6-5329-4d2e-910b-86b76cbfea2a.pdf",
            "news_date": "2025-11-13 13:03:40"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Quarterly Earnings Release dated November 12 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b9a91d7d-d201-42cd-b045-ab87cf64aa04.pdf",
            "news_date": "2025-11-12 17:13:51"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Earnings Presentation for the Quarter and Half year ended September 30 2025",
            "news_id": "34f7353c-a475-4106-937e-3b2e341b8332",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2cddf073-491e-4bdf-907a-5c5e21684dee.pdf",
            "news_date": "2025-11-12 17:02:10",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Earnings Presentation for the Quarter and Half year ended September 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2cddf073-491e-4bdf-907a-5c5e21684dee.pdf",
            "news_date": "2025-11-12 17:02:10"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Standalone And Consolidated Financial Results For Quarter And Half Year Ended September 30 2025",
            "news_body": "Please find enclosed herewith Standalone and Consolidated Financial Results for Quarter and Half Year ended September 30 2025",
            "news_id": "8bfe5d15-6708-4a4d-b78a-acf77cc73c93",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4de6c86b-6731-490d-9bb2-1d0812ee0915.pdf",
            "news_date": "2025-11-12 10:33:38",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Standalone And Consolidated Financial Results For Quarter And Half Year Ended September 30 2025",
            "news_body": "Please find enclosed herewith Standalone and Consolidated Financial Results for Quarter and Half Year ended September 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4de6c86b-6731-490d-9bb2-1d0812ee0915.pdf",
            "news_date": "2025-11-12 10:33:38"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Board Meeting Outcome",
            "news_body": "Please find enclosed herewith the unaudited financial results of the Company for the quarter and half year ended September 30 2025 along with the Limited review report.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5f0aa931-8c1f-4c67-a29c-d389b7661c16.pdf",
            "news_date": "2025-11-12 10:27:45"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform that the Company will host a Conference call for Analysts and Investors to discuss the Un audited financial results of the Company for the quarter ended September 30 2025 on Thursday  November 13 2025 at 04:00 p.m. (IST)\r\n\r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a8529563-4696-4ac4-8a8e-11f5089a66f8.pdf",
            "news_date": "2025-11-10 14:59:43"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Please find enclosed herewith the copy of news paper publication with respect to the special window for re-lodgement of transfer request for physical shares.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5f1ec94d-fc1c-4b1b-bac9-35437fd6e6a2.pdf",
            "news_date": "2025-11-06 14:49:52"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Approval Of The Un-Audited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended 30 September 2025",
            "news_body": "Advanced Enzyme Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2025 inter alia to consider and approve Un-Audited Standalone And Consolidated Financial Results for the Quarter and Half Year ended 30 September 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9b403639-af71-420d-bacb-e1aab59245db.pdf",
            "news_date": "2025-11-04 14:38:37"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Please find enclosed herewith compliance certificate under Regulation 74(5) of SEBI (DP) Regulations 2018 for quarter ended September 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f40a5d92-e687-457e-a9d4-373e4edd5d66.pdf",
            "news_date": "2025-10-08 18:15:17"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "General_Announcements",
            "descriptor": "Allotment of ESOP / ESPS",
            "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
            "news_body": "Please find enclosed herewith disclosure with respect to the allotment of Equity Shares under the Advanced Enzyme Technologies Limited - Employee Stock Option Scheme 2022.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0071a68d-56dd-4aa5-9dae-fe25f70e4a09.pdf",
            "news_date": "2025-10-07 10:52:29"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Please find enclosed herewith the intimation of the trading window closure.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=68b9f534-313b-4a0d-bf45-96fa4e3f07d5.pdf",
            "news_date": "2025-09-26 15:34:08"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclosed herewith Investor Presentation for the Pharma and Healthcare Conference to be held on 23-09-2025.",
            "news_id": "05ceb03f-fcc6-495c-a30c-51dcd2a10759",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=62c3a31a-e1de-4aa3-863b-d598a0d55844.pdf",
            "news_date": "2025-09-22 14:14:59",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclosed herewith Investor Presentation for the Pharma and Healthcare Conference to be held on 23-09-2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=62c3a31a-e1de-4aa3-863b-d598a0d55844.pdf",
            "news_date": "2025-09-22 14:14:59"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Please find enclosed herewith intimation with respect to Pharma and Healthcare conference - by DAM Capital Advisors Limited",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=70b75338-ed51-4aa0-ae57-1db930dce440.pdf",
            "news_date": "2025-09-19 18:11:36"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Please find enclosed herewith copy of the newspaper publication with respect to the IEPF 100 Days Campaign - Saksham Niveshak.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8c951ea9-7c7b-46ee-818c-5d5c9fccec4e.pdf",
            "news_date": "2025-09-11 17:20:10"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the Conference call held on Wednesday August 06 2025 with Analysts and Investors for the Un-audited Financial Results of the Company for the Quarter ended June 30 2025",
            "news_id": "5fbc6032-5828-453f-ac80-e2693f6f465c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=791b6684-0467-4aec-b40f-d153e38e279c.pdf",
            "news_date": "2025-08-11 18:47:46",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the Conference call held on Wednesday August 06 2025 with Analysts and Investors for the Un-audited Financial Results of the Company for the Quarter ended June 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=791b6684-0467-4aec-b40f-d153e38e279c.pdf",
            "news_date": "2025-08-11 18:47:46"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Conference Call for the Un-audited Financial Results for the quarter ended June 30 2025",
            "news_id": "1278bf25-c8a9-4e40-9972-b66b25135ac0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0488ec55-2e27-4e3a-b106-488ff695c9b6.pdf",
            "news_date": "2025-08-06 18:45:51",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Conference Call for the Un-audited Financial Results for the quarter ended June 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0488ec55-2e27-4e3a-b106-488ff695c9b6.pdf",
            "news_date": "2025-08-06 18:45:51"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Enclosed copy of the newspaper publication of Extract of        Un-audited Consolidated Financials Results for the Quarter ended June 30 2025 published in The Financials Express and Mumbai Lakshadeep on August 03 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ec93daf1-8a20-4f02-8078-a96405484ed6.pdf",
            "news_date": "2025-08-04 14:32:02"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press Release titled \"Quarterly Earnings Release\" dated August 02 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8bb8dbb9-e3b6-45b7-a6cd-6f2a7a065784.pdf",
            "news_date": "2025-08-02 15:24:19"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Earnings Presentation for the Quarter ended June 30 2025",
            "news_id": "273cecdb-84cf-4c46-8ac9-fb99344c7252",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6926ddae-87f0-461d-84f9-b39a39161b6d.pdf",
            "news_date": "2025-08-02 15:19:14",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Earnings Presentation for the Quarter ended June 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6926ddae-87f0-461d-84f9-b39a39161b6d.pdf",
            "news_date": "2025-08-02 15:19:14"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended June 30 2025",
            "news_body": "The Board of Directors at its Meeting held on August 02 2025 approved Unaudited Financial Results (Standalone & Consolidated) for the Quarter ended June 30 2025 along with Limited Review Report issued by MSKA & Associates Statutory Auditors of the Company",
            "news_id": "ca7e1d57-5ab5-416c-a6f1-4ac8dbee3d3a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a9520edd-4fae-403e-bc54-86b5396d6ea1.pdf",
            "news_date": "2025-08-02 12:58:59",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended June 30 2025",
            "news_body": "The Board of Directors at its Meeting held on August 02 2025 approved Unaudited Financial Results (Standalone & Consolidated) for the Quarter ended June 30 2025 along with Limited Review Report issued by MSKA & Associates Statutory Auditors of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a9520edd-4fae-403e-bc54-86b5396d6ea1.pdf",
            "news_date": "2025-08-02 12:58:59"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "General_Announcements",
            "descriptor": "Acquisition",
            "caption": "Announcement under Regulation 30 (LODR)-Acquisition",
            "news_body": "The Board of Directors at its Meeting held on August 02 2025 approved an Investment of Rs. 10 million in the Equity Shares of Advanced Nutrazyme Private Limited an existing Wholly Owned Subsidiary",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c24336af-1354-47df-a464-dbd1f6c4eeb1.pdf",
            "news_date": "2025-08-02 12:50:30"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On August 02 2025",
            "news_body": "With reference to the notice of Board Meeting dated July 25 2025 we hereby inform that the Board of Directors at its Meeting held on August 02 2025 (commenced at  11.10 a.m. and concluded at 11.40 a.m.) has inter alia transacted the following business: 1) Approved the Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30 2025. 2) Approved an investment of ? 10 million in the Equity Shares of Advanced Nutrazyme Private Limited an existing Wholly Owned Subsidiary.\r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=46e55db3-4aa4-413b-8e5b-e8342b27f11a.pdf",
            "news_date": "2025-08-02 12:47:15"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Appointment of Secretarial Auditors of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c8fd2325-3af7-436b-9799-132621db2d30.pdf",
            "news_date": "2025-07-31 18:38:36"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
            "news_body": "Please find attached herewith Scrutinizers report and details regarding voting results of the 36th AGM..",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=973aea60-e627-4ddb-9376-af0f4ac4b241.pdf",
            "news_date": "2025-07-31 18:25:40"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform that the Company will host a Conference call for Analysts and Investors to discuss the Un-audited financial results of the Company for the quarter ended June 30 2025 on Wednesday  August 06 2025 at 04:00 p.m. (IST)",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=16161757-1461-4627-b1e4-7ee4931444a7.pdf",
            "news_date": "2025-07-31 15:17:24"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Outcome of AGM",
            "news_body": "Proceedings of the 36th Annual General Meeting (AGM) held on July 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=93c7b800-369c-4790-a8b6-0bba996f83f5.pdf",
            "news_date": "2025-07-30 18:20:02"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "General_Announcements",
            "descriptor": "Acquisition",
            "caption": "Announcement under Regulation 30 (LODR)-Acquisition",
            "news_body": "The Board of Directors of JC Biotech Private Limited (95.72% Subsidiary) at its Meeting held on July 25 2025 has approved a Collaboration of the Subsidiary with Raywatt Solar Power Systems Private Limited (Developer) engaged in the development of group Captive Solar Project to avail the power / electricity requirement through Solar for the said Subsidiarys Plant located at APIIC Growth Centre Gundlapalli Village Ongole Andhra Pradesh.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3fca9787-343d-4930-81db-28ec48984742.pdf",
            "news_date": "2025-07-25 17:30:02"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Approval Of The Un-Audited Standalone And Consolidated Financial Results For The Quarter Ended 30 June 2025",
            "news_body": "Advanced Enzyme Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/08/2025 inter alia to consider and approve Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c978e679-a5ea-484e-b805-34e3aa535373.pdf",
            "news_date": "2025-07-25 15:05:35"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Please find attached herewith newspaper publication with respect to special window provided for re-lodgement of Transfer Request of Physical Shares.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a891038d-1562-4383-86d9-289ccad37573.pdf",
            "news_date": "2025-07-18 17:24:00"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Enclosed copy of the newspaper publication of Notice to Equity Shareholders of the Company regarding transfer of Shares to the Investor Education and Protection Fund (IEPF) and Unclaimed Dividend thereto published in The Financial Express and Mumbai Lakshadeep on July 15 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fa3df2aa-04a8-461b-9785-cc929117f04b.pdf",
            "news_date": "2025-07-15 15:55:52"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "With reference to Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations 2018 enclosed is the certificate for the quarter ended June 30 2025 received from MUFG Intime India Private Limited the Registrar and Transfer Agents of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c4c8747e-db79-4410-b99c-412c2f09f925.pdf",
            "news_date": "2025-07-14 17:07:06"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "General_Announcements",
            "descriptor": "Acquisition",
            "caption": "Announcement under Regulation 30 (LODR)-Updates on Acquisition",
            "news_body": "Please find enclosed herewith disclosure under Regulation 30 of the SEBI (LODR) Regulations with respect to incorporation of Advanced Nutrazyme Private Limited a wholly owned subsidiary of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=39da2ca5-2893-46d9-a828-9a1ad0cc98e4.pdf",
            "news_date": "2025-07-04 15:58:04"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Please find enclosed herewith copies of Newspaper publication with respect to the completion of dispatch of Notice and Integrated Annual report for FY 2024-2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3e3bfea5-637f-4978-8ac1-04b705ff5106.pdf",
            "news_date": "2025-07-04 12:48:32"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "General_Announcements",
            "descriptor": "Business Responsibility and Sustainability Reporting (BRSR)",
            "caption": "Business Responsibility and Sustainability Reporting (BRSR)",
            "news_body": "Please find enclosed herewith Business Responsibility and Sustainability Report for FY 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=28d8699f-01e6-4243-9d7f-46f7f32532dd.pdf",
            "news_date": "2025-07-03 19:15:16"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "General_Announcements",
            "descriptor": "Reg. 34 (1) Annual Report",
            "caption": "Reg. 34 (1) Annual Report.",
            "news_body": "Please find enclosed herewith Integrated Annual report for FY 2024-2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=12471189-42b0-4377-9210-a04def767ceb.pdf",
            "news_date": "2025-07-03 19:11:49"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "General_Announcements",
            "descriptor": "AGM",
            "caption": "Notice Of The 36Th Annual General Meeting Of The Company",
            "news_body": "Please find enclosed herewith Notice of the 36th Annual General Meeting of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a1a11bb9-e86c-48b6-b802-17180bacf6b3.pdf",
            "news_date": "2025-07-03 19:00:41"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "Letter to Shareholders - Integrated Annual Report for FY 2024-2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=54f2fe49-a7ee-4e1e-ae60-26dbd1591d56.pdf",
            "news_date": "2025-07-03 18:00:00"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "We are enclosing herewith the copies of the news paper advertisements published in Financial Express and Mumbai Lakshadeep.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d1968d97-1024-4fbb-a93e-025cce9ab4c4.pdf",
            "news_date": "2025-06-26 15:15:30"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "The trading window for trading in securities of the Company shall remain closed from July 01 2025 till 48 hours after announcement of the Companys Financial Results for Quarter ended June 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6113540c-9fa6-483e-b24e-fcf008af3020.pdf",
            "news_date": "2025-06-25 17:45:15"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of Analyst / Institutional Investor Meeting with Emkay Investment Managers.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b26c5289-02e2-4f15-8bfe-769f99f6541a.pdf",
            "news_date": "2025-06-19 18:24:14"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of Analyst / Institutional Investor Meeting with Minerva Asset Advisors.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=237e8ebf-554f-4d06-8ba3-390db54060e2.pdf",
            "news_date": "2025-05-29 17:47:01"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of Analyst / Institutional Investor Meeting with Monarch Networth Capital Limited.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5b72db25-c5aa-4def-aa50-87a9ae6ed2be.pdf",
            "news_date": "2025-05-29 17:42:53"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of Analyst / Institutional Investor Meeting with UTI Mutual Fund.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=51935757-a79f-4b94-896c-7d1606ac171e.pdf",
            "news_date": "2025-05-23 18:04:28"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of Analyst / Institutional Investor Meeting with Eternity Capital LLP",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ef4f11a3-efe4-42ae-ba55-8df0ce46a96e.pdf",
            "news_date": "2025-05-23 18:00:58"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "Compliance",
            "descriptor": "Reg.24(A)-Annual Secretarial Compliance",
            "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
            "news_body": "Please find attached herewith Annual Secretarial Compliance Report for year ended March 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a2a852cb-8fee-46ad-9daa-97d67c81f6bf.pdf",
            "news_date": "2025-05-23 15:38:30"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "In furtherance to our intimated letter dated May 09 2025 please find enclosed the Transcript of the Conference call held on Wednesday May 14 2025 with Analysts and Investors for the audited Financial Results of the Company for the quarter and year ended March 31 2025",
            "news_id": "0db87b7b-ebf2-401e-aea8-b8e342d6629a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4560608f-45b8-45c5-8573-e1c4c965cc63.pdf",
            "news_date": "2025-05-19 12:18:33",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "In furtherance to our intimated letter dated May 09 2025 please find enclosed the Transcript of the Conference call held on Wednesday May 14 2025 with Analysts and Investors for the audited Financial Results of the Company for the quarter and year ended March 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4560608f-45b8-45c5-8573-e1c4c965cc63.pdf",
            "news_date": "2025-05-19 12:18:33"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of Analyst / Institutional Investor Meeting with CVC Global",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=732a088d-f00d-4a4d-a8f0-1c0fa9414899.pdf",
            "news_date": "2025-05-15 17:15:52"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to the Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 (as amended) the audio recording of the Conference call held today i.e. on Wednesday May 14 2025 on the audited Financial Results for the quarter and year ended March 31 2025 is available on the website of the Company at www.advancedenzymes.com/investors/analyst-corner",
            "news_id": "9fdb799b-ef86-4538-807a-58087095d3ff",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=83ae2855-c1e8-4d68-aad5-b51a73ec0127.pdf",
            "news_date": "2025-05-14 17:57:47",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to the Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 (as amended) the audio recording of the Conference call held today i.e. on Wednesday May 14 2025 on the audited Financial Results for the quarter and year ended March 31 2025 is available on the website of the Company at www.advancedenzymes.com/investors/analyst-corner",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=83ae2855-c1e8-4d68-aad5-b51a73ec0127.pdf",
            "news_date": "2025-05-14 17:57:47"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Enclosed Copy of newspaper publication of Extract of audited Consolidated Financials Results for the quarter and year ended March 31 2025 publised in The Free Press Journal and Mumbai Lakshadeep on May 14 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e89122a9-45e0-469f-adba-81b4e2c9c664.pdf",
            "news_date": "2025-05-14 17:14:09"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor presentation for quarter and year ended March 31 2025.",
            "news_id": "de52f7aa-6a6c-4e0b-80a7-d2eeed83872c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=711f2bd9-953a-4024-8e43-5c987169e560.pdf",
            "news_date": "2025-05-13 19:00:52",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor presentation for quarter and year ended March 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=711f2bd9-953a-4024-8e43-5c987169e560.pdf",
            "news_date": "2025-05-13 19:00:52"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press release titled Quarterly Earnings Release",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8635aba5-6a96-4446-b840-42d576aee103.pdf",
            "news_date": "2025-05-13 18:55:42"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Communication To Shareholders - Intimation On Tax Deduction On Dividend",
            "news_body": "The Board of Directors of the Company at it meeting held on Tuesday May 13 2025 declared an Interim Dividend for the Financial Year 2025-26 at Rs. 4/- per share.\r\n\r\nEnclosed email communication to its Shareholders whose email address are registered with Depository Participants.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3d69c98c-c610-4627-ab9f-b246426b0cab.pdf",
            "news_date": "2025-05-13 18:11:37"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "Intimation",
            "descriptor": "Record Date",
            "caption": "Record Date For Final Dividend.",
            "news_body": "Refer attached file.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4ac09453-b0c1-454a-a270-d353433f34b9.pdf",
            "news_date": "2025-05-13 12:45:36"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "General_Announcements",
            "descriptor": "Acquisition",
            "caption": "Announcement under Regulation 30 (LODR)-Acquisition",
            "news_body": "Approved incorporation of wholly owned subsidiary.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bd5f6d24-d83c-4b7f-b2c1-815270fe50ae.pdf",
            "news_date": "2025-05-13 12:38:48"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Appointment of Secretarial Auditors.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=18287127-1cbe-4b67-af81-ad8ba7503e8e.pdf",
            "news_date": "2025-05-13 12:36:56"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "General_Announcements",
            "descriptor": "Dividend Updates",
            "caption": "Announcement under Regulation 30 (LODR)-Dividend Updates",
            "news_body": "AGM date and record Date",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e0334310-17b5-4f13-b22f-1f9509975520.pdf",
            "news_date": "2025-05-13 12:34:19"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "Outcome",
            "descriptor": "Dividend",
            "caption": "Corporate Action-Board approves Dividend",
            "news_body": "Approved interim dividend.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=56e71718-c565-4c95-b68d-001c81e3da81.pdf",
            "news_date": "2025-05-13 12:31:06"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Standalone And Consolidated Results For FY 2024-25",
            "news_body": "Refer attached file.",
            "news_id": "d4aa0193-febc-44db-838f-6615e7cb0c43",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6e957cb9-46d1-447d-be2b-5079dcf90b37.pdf",
            "news_date": "2025-05-13 12:29:09",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Standalone And Consolidated Results For FY 2024-25",
            "news_body": "Refer attached file.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6e957cb9-46d1-447d-be2b-5079dcf90b37.pdf",
            "news_date": "2025-05-13 12:29:09"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On May 13 2025",
            "news_body": "Please refer to the attached file.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=94f28b54-a72f-431c-8c32-dee4de481a17.pdf",
            "news_date": "2025-05-13 12:22:51"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation on Conference call - Financial Results for the  quarter and year ended March 31 2025.\r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8a8210a3-7a64-4fb6-b19f-0465ea69921b.pdf",
            "news_date": "2025-05-09 14:51:06"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "Intimation",
            "descriptor": "Record Date",
            "caption": "Board To Consider & Declare Interim Dividend If Any For The Financial Year Ended March 31 2026",
            "news_body": "The record date for determining the shareholders for payment of aforesaid interim dividend for FY 2025-26  if declared by the Board shall be Saturday May 17 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=83393dea-9b0d-407b-be3d-2469be2a0a8d.pdf",
            "news_date": "2025-05-06 16:21:04"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Intimation Of Board Meeting Record Date For Interim Dividend If Declared By The Board And Closure Of Trading Window",
            "news_body": "Advanced Enzyme Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2025 inter alia to consider and approve This is to inform that a meeting of the Board of Directors of the Company is scheduled to be held on Tuesday May 13 2025 inter alia to consider the following:\r\n1) To consider & approve annual Financial Statements (Standalone & Consolidated) of the Company for\r\nthe financial year ended March 31 2025 along with results of the fourth quarter;\r\n2) To consider & recommend Final dividend if any for the financial year ended March 31 2025 and/or\r\nto consider & declare Interim Dividend if any for the financial year ended March 31 2026.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3d6e11d6-ff40-4ee1-ab2a-7c46222bfae6.pdf",
            "news_date": "2025-05-06 16:14:04"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "With reference to the Regulation 74(5) of the Securities and Exchange Board of India (Depository and Participants) Regulations 2018 enclosed is the certificate for the quarter ended March 31 2025 received from MUFG Intime India Private Limited (foremerly known as Link Intime India Private Limited) the Registrar and Transfer Agents of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e7625244-842a-463e-888d-5be81609c839.pdf",
            "news_date": "2025-04-09 18:29:00"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation For Grant Of Stock Options Under Advanced Enzyme Technologies Limited - Employees Stock Option Scheme 2022 (The Scheme)",
            "news_body": "The Nomination and Remuneration Committee of the Board of Directors of the Company vide Circular Resolution passed on March 27 2025 has approved the grant of 512500 stock options under the Employees Stock Option Scheme 2022",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c4cded74-7295-4d67-aa90-5acd90a30202.pdf",
            "news_date": "2025-03-27 16:28:07"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Trading window for trading in securities of the company shall remain closed from April 01 2025 till 48 hours after the announcement of financial results for the quarter and year ended March 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4878b5de-f1e6-41ac-9bfe-508f4ccb7185.pdf",
            "news_date": "2025-03-26 17:27:11"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "General_Announcements",
            "descriptor": "Allotment of ESOP / ESPS",
            "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
            "news_body": "The Security Allotment Committee of the Board of Directors of the Company at its meeting held today has approved the allotment of 500 Equity Shares of face value of ? 2 each per share pursuant to the Exercise of Options under Advanced Enzyme Technologies Limited - Employees Stock Options Scheme 2022.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=32b3a853-c1b6-4501-a690-4ecd7d4fce2d.pdf",
            "news_date": "2025-03-19 11:09:45"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of Analyst / Institutional Investor Meeting with Raintree Family Office",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fbb535b8-a55a-4a5e-b4a2-e02f8213d7a8.pdf",
            "news_date": "2025-03-13 16:33:50"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of Analyst / Institutional Investor Meeting with Banyan Capital Advisors",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1f42a376-5890-4eaf-a96a-17757ed9ff20.pdf",
            "news_date": "2025-03-12 11:32:56"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of Analyst / Institutional Investor Meeting  with Motilal Oswal Financial Services Ltd / Royce Investment Partners under the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations 2015.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=03735945-f32c-4783-b243-a7b8604bf245.pdf",
            "news_date": "2025-03-10 14:37:40"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of Analyst / Institutional Investor Meeting with Fidelity International and Dhamma Capital",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d6215bbd-9551-456b-aa42-85cbf883b169.pdf",
            "news_date": "2025-02-27 18:55:50"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of Analyst / Institutional Investor Meeting with CapGrow Capital & ICICI Prudential Asset Management",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=75bf55c2-0cbb-4529-a30f-f5f70cc9042b.pdf",
            "news_date": "2025-02-27 18:53:17"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of Analyst / Institutional Investor Meeting with Grandeur Peak Advisors LLP USA & Ethos Investment Management USA",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e032317a-f234-4638-9d72-8e3abf99ba16.pdf",
            "news_date": "2025-02-27 18:50:01"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of Analyst / Institutional Investor Meeting with Securities Investment Management Pvt Ltd (SIMPL)",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b7d5813f-68c9-4945-98eb-7fb2a563afd5.pdf",
            "news_date": "2025-02-27 18:46:36"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of Analyst / Institutional Investor Meeting with NT Asset Management Thailand",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1e6e7767-afe9-4b35-8e7e-b8085732cfa8.pdf",
            "news_date": "2025-02-27 18:44:25"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "General_Announcements",
            "descriptor": "Credit Rating",
            "caption": "Announcement under Regulation 30 (LODR)-Credit Rating",
            "news_body": "In terms of Regulation 30 and Schedule III to the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 (as amended) we would like to inform that Advanced Enzyme Technologies Limited has received the ratings outstanding for debt instruments /facilities of the Company by CRISIL Ratings Limited (CRISIL) as per enclosed letter received from CRISIL.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=95fd20bf-c07e-4cb7-8905-349c027e5f3c.pdf",
            "news_date": "2025-02-17 18:33:36"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "In futherance to our intimation letter dated February 03 2025 please find enclosed the Transcript of the Conference Call held on Wednesday February 12 2025 with Analysts and Investors for the un-audited Financial Results of the Company for the quarter and nine months ended December 31 2024.\r\n\r\nThe aforesaid information is also being uploded on the website of the Company",
            "news_id": "52577e53-6ccb-4cd5-946d-6cdc77d95259",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e589c260-74b6-4f8c-b2a8-59f244d6646c.pdf",
            "news_date": "2025-02-17 14:32:06",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "In futherance to our intimation letter dated February 03 2025 please find enclosed the Transcript of the Conference Call held on Wednesday February 12 2025 with Analysts and Investors for the un-audited Financial Results of the Company for the quarter and nine months ended December 31 2024.\r\n\r\nThe aforesaid information is also being uploded on the website of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e589c260-74b6-4f8c-b2a8-59f244d6646c.pdf",
            "news_date": "2025-02-17 14:32:06"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to the Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 (as amended) the audio recording of the Conference call held today i.e. on Wednesday February 12 2025 on the Un-audited Financial Results for the quarter and nine months ended December 31 2024 is available on the Companys website at www.advancedenzymes.com/investors/analyst-corner",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=021b2a2c-4462-4cf4-b8ee-5b564bd9c160.pdf",
            "news_date": "2025-02-12 18:16:46"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Pursuant to the provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 please find enclosed copy of the newspaper publication of Extract of Un-audited Consolidated Financial Results for the quarter and nine months ended December 31 2024 published in The Financial Express and Mumbai Lakshadeep on February 09 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=762c2469-49f7-458a-8ed6-db5892de9e1f.pdf",
            "news_date": "2025-02-10 15:38:47"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "General_Announcements",
            "descriptor": "Integrated Filing (Financial)",
            "caption": "Integrated Filing (Financial)",
            "news_body": "Integrated Financial Statement for quarter and nine months ended December 31 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d02d00dc-6049-4cc5-ab0f-77e83ce1ca3e.pdf",
            "news_date": "2025-02-08 23:33:43"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Earning Presentation- Third Quarter FY2024-25",
            "news_id": "18c1c664-558b-4a34-ae35-642d603e1d23",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8ceeeff9-94ba-48db-8f39-70eb44eb95a6.pdf",
            "news_date": "2025-02-08 21:20:04",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Earning Presentation- Third Quarter FY2024-25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8ceeeff9-94ba-48db-8f39-70eb44eb95a6.pdf",
            "news_date": "2025-02-08 21:20:04"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press Release- Third Quarter FY 2024-2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=55f0ea2b-2a50-4aab-8ff4-8e143db1291d.pdf",
            "news_date": "2025-02-08 20:59:28"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results (Standalone & Consolidated) Of The Company For The Quarter And Nine Months Ended December 31 2024",
            "news_body": "Advanced Enzyme Technologies Limited has informed the Exchange about the Unaudited Financial Results (Standalone & Consolidated) of the Company for the quater and nine months ended December 31 2024\r\n\r\nThe aforesaid financial results are also being uploaded on the website of the Company i.e. www.advancedenzymes.com",
            "news_id": "e1bf5d21-6ddd-4878-981e-5285794a7869",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=64cda602-363d-4682-8a8a-55df1f381f4f.pdf",
            "news_date": "2025-02-08 12:50:48",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Unaudited Financial Results (Standalone & Consolidated) Of The Company For The Quarter And Nine Months Ended December 31 2024",
            "news_body": "Advanced Enzyme Technologies Limited has informed the Exchange about the Unaudited Financial Results (Standalone & Consolidated) of the Company for the quater and nine months ended December 31 2024\r\n\r\nThe aforesaid financial results are also being uploaded on the website of the Company i.e. www.advancedenzymes.com",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=64cda602-363d-4682-8a8a-55df1f381f4f.pdf",
            "news_date": "2025-02-08 12:50:48"
        },
        {
            "co_code": 19816,
            "bse_code": 540025,
            "isin": "INE837H01020",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On February 08 2025",
            "news_body": "With reference to the notice of Board Meeting dated February 01 2025 we hereby inform that the Board of Directors at its Meeting held on February 08 2025 has inter-alia approved the Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter and nine months ended December 31 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1be082e4-c53f-4289-98e5-a80ab73df077.pdf",
            "news_date": "2025-02-08 12:38:57"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the Conference Call held on Wednesday, November 13, 2024 with Analysts and Investors for the Un-audited Financial Results of the Company for the quarter and half year ended September 30, 2024",
            "news_id": "4c2b59be-170e-4cec-850f-f3339fd0f93f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3c75e7ab-ee58-4811-91a5-b4cc0acadff5.pdf",
            "news_date": "2024-11-19 12:46:41",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Conference Call for the Un-audited Financial Results for the quarter and half year ended September 30, 2024",
            "news_id": "52594091-3f65-4d38-84c2-ea1b9596c403",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b1b22f0e-ba0e-40f1-8895-f005c09b8a23.pdf",
            "news_date": "2024-11-13 18:12:12",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Earnings Presentation for the quarter and half year ended September 30, 2024",
            "news_id": "7d7663c8-ba9c-4ca3-9abe-656ebd8d0577",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a3a15dbe-f8b6-498a-84dd-51d08b919e78.pdf",
            "news_date": "2024-11-09 14:57:09",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Held On November 09, 2024",
            "news_body": "Un-audited Financial Results (Standalone and Consolidated) of the Company for the Quarter and Haly year ended September 30, 2024",
            "news_id": "3cb99aa2-cee9-4f67-82b7-838b3a373ecc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4d54dbb2-3984-41df-919c-409a123ee6b5.pdf",
            "news_date": "2024-11-09 10:56:46",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On November 09, 2024",
            "news_body": "With reference to the notice of Board Meeting dated November 09, 2024, we hereby inform that the Board of Directors at its Meeting held on November 09, 2024 has inter-alia approved the Unaudited Financial Results (Standalone & Consolidated ) of the Company for the quarter and half year ended September 30, 2024",
            "news_id": "7791dcb2-6e24-4aca-acc9-36de05faf99b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7a1e0922-6e89-4910-bc42-d9d726acb56b.pdf",
            "news_date": "2024-11-09 10:52:45",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording - Conference Call - Un-audited Financial Results for the quarter ended June 30, 2024",
            "news_id": "de50e64d-74fc-48ab-a4ea-f0a8b904b7a0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=645fbac8-22b4-40ff-b79f-a4929fc9d54b.pdf",
            "news_date": "2024-08-13 18:19:38",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Earnings Presentation for the Quarter ended June 30, 2024",
            "news_id": "0a544841-8772-4dc9-9e27-fe3de015d3c9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d2d34c4f-043b-42f5-a280-f5e4bcbe329f.pdf",
            "news_date": "2024-08-10 15:39:48",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Statement Of Un-Audited Financial Results (Standalone And Consolidated) Of The Company For The Quarter Ended June 30, 2024",
            "news_body": "Un-Audited Financial Results (Standalone and Consolidated) for the Quarter ended June 30, 2024",
            "news_id": "b89c406e-6492-4cf6-a2b9-baa46735dd2b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5058de09-a7cc-4b2d-9e07-6b309a32aadd.pdf",
            "news_date": "2024-08-10 11:16:55",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the Conference Call held on Wednesday, May 15, 2024 with Analysts and Investors for the auidted Financial Results of the Company for quarter and year ended March 31, 2024",
            "news_id": "3af42deb-21e6-49dd-995b-4ecae532c0f0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7bbd7851-d460-4af9-ab19-5fbc14c339e9.pdf",
            "news_date": "2024-05-21 17:31:33",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to the Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended), the audio recording of the Conference call held today i.e. on Wednesday, May 15, 2024 on the audited Financial Results for the quarter and year ended March 31, 2024, is available on the website of the Company at www.advancedenzymes.com/investors/analyst-corner",
            "news_id": "4c5a0615-35c4-4fa9-b952-723952ab2490",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b83305e5-7df2-46ca-b2f4-99f1679e391a.pdf",
            "news_date": "2024-05-15 18:20:20",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Securities and Exchange Board of India (Listing Obligations and Disclosure Requirement) Regulations, 2015. enclosed is Earning Presentation for the quarter and year ended March 31, 2024",
            "news_id": "89cc1ec8-c4b0-4b7e-829d-c0a24646fb34",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=699fe136-4fe5-4cd3-9b3b-e111d1c608b3.pdf",
            "news_date": "2024-05-11 18:12:29",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Statement (Standalone And Consolidated) Of The Company For The Financial Year Ended March 31, 2024",
            "news_body": "Audited Financial Statement (Standalone and Consolidated)of the Company for the Financial year ended March 31, 2024",
            "news_id": "53510534-f506-4806-b53f-013698377058",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ea5e0230-261a-4aa0-9bc3-4fb88c2f5bd0.pdf",
            "news_date": "2024-05-11 13:40:51",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "In furtherance to our intimation letter dated February 10, 2024, please find enclosed the Transcript of the Conference call held on Friday, February 16, 2024 with Analysts and Investors for the un-audited Financial Results of the Company for the quarter and nine months ended December 31, 2023",
            "news_id": "b927e867-ce5e-4207-a319-0f56fd961f79",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=addcd500-fbd6-48cb-b321-cd591ff15a4d.pdf",
            "news_date": "2024-02-21 12:23:55",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of conference call held today",
            "news_id": "e0e6f1cb-ca07-4ef4-b632-2a6653e290ef",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=02db4abf-a3db-4e9f-8b44-80d557cefae4.pdf",
            "news_date": "2024-02-16 18:22:17",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Earnings Presentation for the quarter and nine months ended December 31, 2023",
            "news_id": "008abc72-5987-4bcd-98bc-17004f448335",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b7d061d9-421a-41c6-a004-93fd85d6775e.pdf",
            "news_date": "2024-02-10 16:28:30",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Statement Of Un-Audited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Nine Months Ended December 31, 2023",
            "news_body": "Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter and nine months ended December 31, 2023",
            "news_id": "1f757075-4637-40a7-b437-2aebe903b4e4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0fd9acf7-8038-48b6-ba54-72c34ad6a6f8.pdf",
            "news_date": "2024-02-10 12:41:32",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "In furtherance to our intimation letter dated November 01, 2023, Please find enclosed the Transcript of the Conference call held on Friday, November 10, 2023 with Analysts and Investors for the un-audited Financial Results of the Company for the quarter and half year ended September 30, 2023.",
            "news_id": "a7b1a411-f14d-437d-8fba-459c8f46650d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6d03babb-435b-46dc-8361-9e3c8557dbd3.pdf",
            "news_date": "2023-11-17 14:58:37",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended), the audio recording of the Conference call held on Friday, November 10, 2023 on the Un-audited Financial Results for the quarter and half year ended September 30, 2023, is available on the Company's website at https://www.advancedenzymes.com/investors/analyst-corner",
            "news_id": "f8336c21-8660-44ff-83a4-b5f6d47f3df1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dd062ab0-5e9d-4a7a-ab31-39c8b97276ef.pdf",
            "news_date": "2023-11-11 10:18:13",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Earnings Presentation for the quarter and half year ended September 30, 2023",
            "news_id": "81d30723-9c47-47e3-b119-900e3817b5ba",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=172c00c1-51ba-45d1-914a-e456d48e450d.pdf",
            "news_date": "2023-11-07 16:21:07",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Held On November 07, 2023",
            "news_body": "Outcome of Board Meeting held on November 07, 2023",
            "news_id": "1e20e802-191d-4326-8fa0-82315b42a799",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=192f4409-7ee7-4ad6-8d8c-4c011f642325.pdf",
            "news_date": "2023-11-07 12:25:47",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Held On November 07, 2023",
            "news_body": "with reference to the notice of Board Meeting dated October 31, 2023, we hereby inform that the Board of Directors at its Meeting held on November 07, 2023 has inter-alia approved the unaudited financial results (Standalone & Consolidated ) of the Company for the quarter and half year ended September 30, 2023.",
            "news_id": "10e3827b-520b-4a85-938f-556f5d1c7628",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=09667154-ade7-4911-ac37-7db234b155e6.pdf",
            "news_date": "2023-11-07 12:22:43",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On November 07, 2023",
            "news_body": "With reference to the notice of Board Meeting dated October 31, 2023, we hereby inform that the Board of Directors at its Meeting held on November 07, 2023 (commenced at 11.25 a.m. and concluded at 11.55 a.m.) has inter alia, approved the Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter and half year ended September 30, 2023.<BR> <BR> In view of the aforesaid, we are enclosing Annexure I - Unaudited Financial Results (Standalone & Consolidated) for the quarter and half year ended September 30, 2023 along with the Limited Review report issued by MSKA & Associates, Statutory Auditors of the Company as an Annexure.<BR> <BR> The aforesaid financial results and other documents are also being uploaded on the website of the Company i.e. www.advancedenzymes.com<BR> <BR> This is for your information and for public at large.<BR>",
            "news_id": "d1925ff1-3783-43f4-9ba1-07f8bea29c36",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1a557244-6567-4289-a211-39f75a22ef7d.pdf",
            "news_date": "2023-11-07 12:13:45",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "In futherance to our intimation letter dated August 07, 2023, please find enclosed the Transcript of the Conference Call held on Wednesday, August 16, 2023 with Analyst and Investors for the un-audited Financial Results of the Company for the quarter ended June 30, 2023",
            "news_id": "ecb5355b-891c-4170-87d8-bf86bbd86fd5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0164793f-273e-4cae-be8d-33bca752dd43.pdf",
            "news_date": "2023-08-23 10:12:01",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended), the audio recording of the Conference call held today i.e. on Wednesday, August 16, 2023 on the Un-audited Financial Results for the quarter ended June 30, 2023, is available on the Company's website at https://www.advancedenzymes.com/investors/analyst-corner",
            "news_id": "57c29ed6-8cbf-4c83-bdbd-c16de0a58266",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5aec0faa-533e-4d4a-b06f-5633a669682b.pdf",
            "news_date": "2023-08-16 18:46:24",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Earning Presentation for the quarter ended June 30, 2023",
            "news_id": "fec10d2e-fff0-4f86-b470-5879ac672394",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5b23663f-4800-4d9d-93a4-fa42bf64a677.pdf",
            "news_date": "2023-08-12 13:11:19",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Statement Of Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended 30Th June, 2023",
            "news_body": "Statement of Unaudited Standalone and Consolidated Financial Results of the Company for the Quater ended 30th June 2023",
            "news_id": "f56b9b43-a761-4bd2-99af-614711593e47",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f63ecc33-c25e-4745-9c2d-9b36ed6e1962.pdf",
            "news_date": "2023-08-12 11:12:17",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "In furtherance to our intimation letter dated May 12, 2023, please find enclosed the Transcript of the Conference call held on Monday, May 15, 2023 with Analysts and Investors for the audited Financial Results of the Company for the quarter and year ended March 31, 2023.",
            "news_id": "55f027a5-a2af-4fa6-9c43-110907cb57d5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5fe70be3-699d-441d-8b5b-9b091cd1f148.pdf",
            "news_date": "2023-05-18 16:56:25",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended), the audio recording of theConference call held today i.e. on Monday, May 15, 2023 on the audited Financial Results for the quarter and year ended March 31, 2023, is available on the website of the Company at https://www.advancedenzymes.com/investors/analyst-corner",
            "news_id": "38e9ecb2-b6e4-46ef-9fb6-03a8ccb9f657",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9ece76a0-8de0-4e7f-9896-f75427bbd0a3.pdf",
            "news_date": "2023-05-15 19:12:44",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed is Earnings Presentation for the quarter and yearended March 31, 2023.",
            "news_id": "68d6d128-bad3-4768-abfd-46aacbbc38ec",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=acb29140-0ad6-48e5-9507-3aa1d0536bf7.pdf",
            "news_date": "2023-05-13 16:36:52",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results (Standalone & Consolidated) For The Quarter And Financial Year Ended March 31, 2023",
            "news_body": "Advanced Enzyme Technologies Limited has informed the Exchange about the Audited Financial Results (Standalone & Consolidated) for the quarter and financial year ended March 31, 2023 along with the Auditor''s Report issued by MSKA & Associates, Statutory Auditors of the CompanyThe aforesaid financial results and other documents are also being uploaded on the website of the Company i.e. www.advancedenzymes.com",
            "news_id": "8f6f0f12-0a1c-4ad6-9f50-dd3e26d3f238",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=57323751-f807-4b08-ab4d-2853a90dcb06.pdf",
            "news_date": "2023-05-13 13:29:00",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Furtherance to our intimation letter dated February 07, 2023, please find enclosed the Transcript of the Conference call held on Tuesday, February 14, 2023 with Analysts and Investors for the un-audited Financial Results of the Company for the quarter and nine months ended December 31, 2022.",
            "news_id": "0f4099fc-a3c3-4024-8103-a493d1a0fe12",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4173f2db-a938-42df-8500-bdf52dee65ea.pdf",
            "news_date": "2023-02-17 20:16:42",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Conference call held today i.e. on Tuesday, February 14, 2023 on the Un-audited Financial Results for the quarter and nine months ended December 31, 2022",
            "news_id": "61239bff-edb1-4208-abd1-72a4dd1e2575",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3d952fd2-f2a3-4ecf-9c66-b21172f467d0.pdf",
            "news_date": "2023-02-14 17:41:33",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Earnings Presentation for the quarter ended December 31, 2022",
            "news_id": "0281088f-ba82-4428-908a-3816a4c55346",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2f869463-731f-45ef-aa94-2d3f6b9458e6.pdf",
            "news_date": "2023-02-11 14:54:33",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On February 11, 2023",
            "news_body": "With reference to the notice of Board Meeting dated February 04, 2023, we hereby inform that the Board of Directors of the Company at its meeting held on February 11, 2023 (commenced at 11.25 a.m. and concluded at 12.10 p.m.) has inter alia, transacted the following business: <BR> <BR> Approved the Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter and nine months ended December 31, 2022.<BR> <BR> Approved the allotment of 2,000 Equity Shares of face value of Rs. 2/- at an exercise price of  Rs. 60/- per share pursuant to exercise of options under the Employees Stock Option Scheme, 2015.<BR> <BR> In view of the aforesaid, we are enclosing the following:<BR> Unaudited Financial Results (Standalone & Consolidated) for the quarter and nine months ended December 31, 2022 along with the Limited Review report issued by MSKA & Associates, Statutory Auditors of the Company, as Annexure I to this letter.<BR> <BR> This is for your information and for public at large. <BR>",
            "news_id": "14ee07bf-cdca-491c-8638-0b672ac6a1cb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ec997bf5-4c23-4631-9097-e1597e68ecdc.pdf",
            "news_date": "2023-02-11 12:18:14",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Under Regulation 23(9) Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Details OfRelated Party Transactions.",
            "news_body": "Pursuant to the provisions of Regulation 23(9) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed is the relevant disclosure on Related Party Transactions for the half year ended September 30, 2022, in the format specified under the SEBI Circular bearing reference no. SEBI/HO/CFD/CMD1/CIR/P/2021/662 dated November 22, 2021.",
            "news_id": "b27af0f9-ff7d-4fed-881a-11a71d9a0b28",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bcb64271-9ff1-42e9-bb39-a512f57a43af.pdf",
            "news_date": "2022-11-25 12:50:45",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Furtherance to our intimation letter dated November 08, 2022, please find enclosed the Transcript of the Conference call held on Tuesday, November 15, 2022 with Analysts and Investors for the un-audited Financial Results of the Company for the quarter and half year ended September 30, 2022.",
            "news_id": "e5bb2d45-ad50-4399-a3af-c0e012ba1ff0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5cec976a-063d-4d29-b2b9-f549a09a8a57.pdf",
            "news_date": "2022-11-21 12:31:47",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Conference call held today i.e. on Tuesday, November 15, 2022 on the Un-audited Financial Results for the quarter and half year ended September 30, 2022",
            "news_id": "69d8db3a-e230-4fa0-b14c-75562eacf07a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a7aa204f-544b-42ae-9e84-8c877d134b2c.pdf",
            "news_date": "2022-11-15 18:53:25",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Earnings Presentation for the quarter ended September 30, 2022",
            "news_id": "f792b80e-bfcf-4b4c-9957-c5e7ece885a1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=780e07ca-6420-4b81-bc09-41b7d72a629c.pdf",
            "news_date": "2022-11-11 17:33:18",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On November 11, 2022",
            "news_body": "With reference to the Board meeting notice dated November 04, 2022, we hereby inform that the Board of Directors in its meeting held on November 11, 2022 (commenced at 11:15 a.m. and concluded at 12:15 p.m.) has inter-alia, approved the Unaudited Financial Results of the Company (Standalone & Consolidated) for the quarter and half year ended September 30, 2022.<BR> <BR> In view of the aforesaid, we hereby enclose the following:<BR> <BR> Unaudited Financial Results (Standalone & Consolidated) for the quarter and half year ended September 30, 2022 along with the Limited Review Report issued by M S K A & Associates, Statutory Auditors of the Company.<BR> This is for your information and for public at large.<BR>",
            "news_id": "3933d36b-c499-4fb6-8921-5e1600564640",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f8b04e14-3017-4db0-a146-f39956dfa5a3.pdf",
            "news_date": "2022-11-11 12:39:14",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Furtherance to our intimation letter dated August 02, 2022, please find enclosed the Transcript of the Conference call held on Saturday, August 06, 2022 with Analysts and Investors for the un-audited Financial Results of the Company for the quarter ended June 30,2022.",
            "news_id": "7d4cab1a-6915-4b10-845f-5c4d556ee962",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cd2f8ce1-a27c-45f5-b893-fdaad319599e.pdf",
            "news_date": "2022-08-09 13:56:34",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Earnings Presentation for the quarter ended June 30, 2022",
            "news_id": "957ca8e7-6adb-472d-af49-0c2842325f89",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=79dfaea4-83e1-45dd-a69d-5dc8d6ef4f90.pdf",
            "news_date": "2022-08-06 13:02:51",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Board Meeting Outcome For Unaudited Financial Results Of The Company (Standalone And Consolidated) For The Quarter Ended June 30, 2022",
            "news_body": "With reference to the Board meeting notice dated July 30, 2022, we hereby inform that the Board of Directors in its meeting held on August 06, 2022 (commenced at 10:00 a.m. and concluded at 10:45 a.m.) has inter-alia, approved the Unaudited Financial Results of the Company (Standalone & Consolidated) for the quarter ended June 30, 2022.<BR> <BR> In view of the aforesaid, we hereby enclose the following:<BR> Unaudited Financial Results (Standalone & Consolidated) for the quarter ended June 30, 2022 along with the Limited Review Report issued by M S K A & Associates, Statutory Auditors of the Company.<BR> <BR> This is for your information and for public at large.<BR>",
            "news_id": "9a1060e4-6132-4213-841f-c1cb1e9c94fb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=71f4d7f9-72ed-406b-b758-1bfb22a598ef.pdf",
            "news_date": "2022-08-06 10:58:45",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions For The Half Year Ended March 31, 2022",
            "news_body": "Pursuant to the provisions of Regulation 23(9) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed is the relevant disclosure on Related Party Transactions of the Company in the format specified under SEBI Circular bearing reference no. SEBI/HO/CFD/CMD1/CIR/P/2021/662 dated November 22, 2021, for the half year ended March 31, 2022.",
            "news_id": "3e2edb18-ba05-4c08-b425-3ba5d11c6cb5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=db5ae33c-fe3b-4ca8-aac6-745c2b7b7fb6.pdf",
            "news_date": "2022-06-03 19:25:29",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "In furtherance to our intimation letter dated May 17, 2022, please find enclosed the Transcript of the Conference call held on Monday, May 23, 2022 with Analysts and Investors for the Audited Financial Results of the Company for the Financial Year ended March 31, 2022 along with the fourth quarter results.",
            "news_id": "905fe3d2-c6fd-4b8c-a468-b6ab1a2737ce",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=97e66575-1dc5-472a-94c1-06e9a208d52e.pdf",
            "news_date": "2022-05-27 16:57:45",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Conference call held today i.e. on Monday, May 23, 2022 on the Audited Financial Results of the Company for the fourth quarter and financial year ended March 31, 2022",
            "news_id": "0a634bed-63ea-4b5f-8f44-46b55d375458",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a8987853-a34f-4501-9b50-e2a13bafd22f.pdf",
            "news_date": "2022-05-23 17:47:58",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Earnings Presentation for the fourth quarter and financial year ended March 31, 2022",
            "news_id": "948a4c58-cb65-4750-a71d-294c3e646ec7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b938764a-674f-4938-bcb7-0a94c02e1f13.pdf",
            "news_date": "2022-05-20 14:43:25",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results (Standalone & Consolidated) For The Quarter And Financial Year Ended March 31, 2022",
            "news_body": "Advanced Enzyme Technologies Limited has informed the Exchange about the Audited Financial Results (Standalone & Consolidated) for the quarter and financial year ended March 31, 2022 along with the Auditor's Report issued by MSKA & Associates, Statutory Auditors of the Company<BR> <BR> The aforesaid financial results and other documents are also being uploaded on the website of the Company i.e. www.advancedenzymes.com<BR>",
            "news_id": "caae7416-c9fa-4862-8fcb-4d26f072c789",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ea44dd0a-2a18-445a-be49-a3efb64bb991.pdf",
            "news_date": "2022-05-20 12:02:17",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On May 20, 2022",
            "news_body": "With reference to the Board meeting notice dated May 12, 2022, we hereby inform that the Board of Directors in its meeting held on May 20, 2022 (commenced at 11:00 a.m. and concluded at 11:45 a.m.) has inter-alia, transacted the following business :<BR> Audited Financial Results (Standalone & Consolidated) for the quarter and financial year ended March 31, 2022 along with the Auditor's Report issued by MSKA & Associates, Statutory Auditors of the Company.<BR> Recommended a Dividend @ 50% i.e. Rs. 1/- per equity share on the face value of Rs. 2/- each for the financial year ended March 31, 2022, subject to the approval of the Shareholders at the ensuing 33rd Annual General Meeting of the Company (''AGM'').<BR> Allotted 5,900 Equity Shares of face value of Rs. 2/- at an exercise price of Rs. 60/- per share pursuant to exercise of options under the Employees Stock Option Scheme, 2015.<BR> <BR> This is for your information and for public at large.<BR>",
            "news_id": "331ca44b-1779-49c3-ad13-e0cd949e5dfb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=da872b9f-ec6e-43a6-957e-1b31f9e7ed96.pdf",
            "news_date": "2022-05-20 11:59:20",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "In furtherance to our intimation letter dated February 03, 2022, please find enclosed the Transcript of the Conference call held on Tuesday, February 08, 2022 with Analysts and Investors for the un-audited Financial Results of the Company for the quarter and nine months ended December 31, 2021",
            "news_id": "e38d69fe-5bff-47d7-84b4-4dd6dea24d57",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2f0a1d71-4a8b-4a8f-9dcd-86481da3d973.pdf",
            "news_date": "2022-02-12 18:32:38",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Earnings Presentation for the quarter and nine months ended December 31, 2021",
            "news_id": "ae5b4c2b-4142-449a-8526-f91bd70fd8a3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d7c7d146-a92d-4915-9192-601ce052ef05.pdf",
            "news_date": "2022-02-05 15:49:36",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results (Standalone & Consolidated) For The Quarter And Nine Months Ended December 31, 2021",
            "news_body": "Advanced Enzyme Technologies Limited has informed the Exchange about the Unaudited Financial Results (Standalone & Consolidated) for the quarter and nine months ended December 31, 2021 along with the Limited Review report issued by M S K A & Associates, Statutory Auditors of the Company.<BR> <BR> The aforesaid financial results along with Limited review report are also being uploaded on the website of the Company, i.e. www.advancedenzymes.com<BR>",
            "news_id": "aa176f02-0b36-4129-8636-a7a032030dae",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=699153e7-639f-4dd4-9ada-f118e64bbe9e.pdf",
            "news_date": "2022-02-05 11:48:13",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "With reference to the Board meeting notice dated January 28, 2022, we hereby inform that the Board of Directors in its meeting held on February 05, 2022 (commenced at 10:55 a.m. and concluded at 11:30 a.m.) has inter-alia, approved the Unaudited Financial Results of the Company (Standalone & Consolidated) for the quarter and nine months ended December 31, 2021.<BR> <BR> In view of the aforesaid, we hereby enclose the following:<BR> Unaudited Financial Results (Standalone & Consolidated) for the quarter and nine months ended December 31, 2021 along with the Limited Review Report issued by M S K A & Associates, Statutory Auditors of the Company.<BR> Allotted 9,200 Equity Shares of face value of Rs. 2/- at an exercise price of Rs. 60/- per share pursuant to exercise of options under the Employees Stock Option Scheme, 2015.<BR> <BR> This is for your information and for public at large.<BR>",
            "news_id": "326d648f-8075-46c7-8538-6be030d39f0b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=32589664-6b37-4af8-816b-62fed65dcb73.pdf",
            "news_date": "2022-02-05 11:44:10",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "In furtherance to our intimation letter dated October 28, 2021, please find enclosed the Transcript of the Conference call held on Wednesday, November 03, 2021 with Analysts and Investors for the un-audited Financial Results of the Company for the quarter and half year ended September 30, 2021.",
            "news_id": "a54fa5df-6c0d-4037-be9d-d2be8b84fbdc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eef1628e-1e35-428a-9e43-4f9c0ccc2ae0.pdf",
            "news_date": "2021-11-08 18:27:39",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Revised Earnings Presentation for the quarter and half year ended September 30, 2021",
            "news_id": "0950efff-70b1-48d0-b3f7-3173d80a393b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c0f6cdb8-c346-4de9-a2bb-bc312eb7e362.pdf",
            "news_date": "2021-11-02 18:05:44",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Earnings Presentation for the quarter and half year ended September 30, 2021",
            "news_id": "32c7a283-a6da-40f3-8ec3-6bc3fc109dea",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2d0a753f-195a-4c16-82c0-90512f787ee3.pdf",
            "news_date": "2021-11-02 12:18:36",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "With reference to the Board meeting notice dated October 26, 2021, we hereby inform that the Board of Directors in its meeting held on November 02, 2021 (commenced at 10:49 a.m. and concluded at 11:35 a.m.) has inter-alia, approved the Unaudited Financial Results of the Company (Standalone & Consolidated) for the quarter and half year ended September 30, 2021.<BR> <BR> In view of the aforesaid, we hereby enclose the following:<BR> Unaudited Financial Results (Standalone & Consolidated) for the quarter and half year ended September 30, 2021 along with the Limited Review Report issued by M S K A & Associates, Statutory Auditors of the Company.<BR> Press Release and Earnings Presentation for the quarter and half year ended September 30, 2021.<BR> Allotted 13,175 Equity Shares of face value of Rs. 2/- at an exercise price of Rs. 60/- per share pursuant to exercise of options under the Employees Stock Option Scheme, 2015.<BR> <BR> This is for your information and for public at large.",
            "news_id": "90dc9a63-9c76-4a4e-b3b7-dc3001509211",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c3b5df7f-2724-4df9-8e94-e820d1e0bc24.pdf",
            "news_date": "2021-11-02 12:05:40",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results (Standalone & Consolidated) For The Quarter And Half Year Ended September 30, 2021",
            "news_body": "Advanced Enzyme Technologies Limited has informed the Exchange about the Unaudited Financial Results (Standalone & Consolidated) for the quarter and half year ended September 30, 2021 along with the Limited Review report issued by M S K A & Associates, Statutory Auditors of the Company.",
            "news_id": "375e15ec-42e6-4305-a8df-e692e35af789",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=efff69dc-b386-421c-83c4-8da09757849e.pdf",
            "news_date": "2021-11-02 12:02:54",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Further to the intimation dated September 28, 2021 and September 30, 2021, please find attached copy of the presentation as may be made by the Company at Motilal  Oswal Biotech and Medtech Day (virtual group meeting) scheduled to held today i.e. October 01, 2021",
            "news_id": "e95c4e95-358e-4b73-97eb-c022697ab6d1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f8ca2877-3332-4be1-a68b-76cc42e3d1c2.pdf",
            "news_date": "2021-10-01 11:09:50",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "In furtherance to our intimation letter dated August 08, 2021, please find enclosed the Transcript of the Conference call held on Wednesday, August 11, 2021 with Analysts and Investors for the un-audited Financial Results of the Company for the quarter ended June 30, 2021.",
            "news_id": "80c01ae3-b492-406d-b31a-04891aa3d8f1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=123eb446-ad51-4c96-b9b6-2750580ca2c5.pdf",
            "news_date": "2021-08-14 21:03:11",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Earnings Presentation for the quarter ended June 30, 2021",
            "news_id": "fed74805-fad7-4c1d-afad-6337425c4e2b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4726b7d9-76cf-460b-b1b0-52e57eb59d7d.pdf",
            "news_date": "2021-08-07 12:46:39",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results (Standalone & Consolidated) For The Quarter Ended June 30, 2021",
            "news_body": "Advanced Enzyme Technologies Limited has informed the Exchange about the Unaudited Financial Results (Standalone & Consolidated) for the quarter ended June 30, 2021 along with the Limited Review report issued by B S R & Co. LLP, Statutory Auditors of the Company.<BR> <BR> The aforesaid financial results along with Limited review report are also being uploaded on the website of the Company, i.e. www.advancedenzymes.com",
            "news_id": "a4db9b4b-d5b7-4547-8e1c-a3ce102beca8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bb43b63d-3d8f-44ec-98ae-01568dacc270.pdf",
            "news_date": "2021-08-07 12:34:55",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "With reference to the Board meeting notice dated July 31, 2021, we hereby inform that the Board of Directors in its meeting held on August 07, 2021 has inter-alia, approved the Unaudited Financial Results of the Company (Standalone & Consolidated) for the quarter ended June 30, 2021.<BR> <BR> In view of the aforesaid, we hereby enclose the following:<BR> Unaudited Financial Results (Standalone & Consolidated) for the quarter ended June 30, 2021 along with the Limited Review report issued by B S R & Co. LLP, Statutory Auditors of the Company as an Annexure.<BR> <BR> This is for your information and for public at large.",
            "news_id": "16e3a7c5-ba79-4af4-a1e5-2b56638194f1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7a009e13-40c7-4037-8ad7-34999de77d54.pdf",
            "news_date": "2021-08-07 12:30:27",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Under Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('SEBI LODR') - Details Of Related Party Transactions On Consolidated Basis",
            "news_body": "Pursuant to the provisions of Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed is the relevant disclosure on Related Party Transactions (on consolidated basis) of the Company for the half year ended March 31, 2021.",
            "news_id": "c235a43f-d8cb-40b9-9b34-694bfa4203ab",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f92a4ee3-55c3-4ee0-b7b3-7bc08afb388a.pdf",
            "news_date": "2021-06-24 18:35:50",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "In furtherance to our intimation letter dated May 26, 2021, please find enclosed the Transcript of the Conference call held on Monday, May 31, 2021 with Analysts and Investors for the Audited Financial Results of the Company for the quarter and financial year ended March 31, 2021.",
            "news_id": "95685673-6c62-4093-b558-29c8746bb474",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eb4c8288-829f-435b-b5be-550df91a7ada.pdf",
            "news_date": "2021-06-03 17:53:27",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results (Standalone & Consolidated) For The Quarter And Financial Year Ended March 31, 2021",
            "news_body": "The Company has informed the Exchange about the Audited Financial Results (Standalone & Consolidated) for the quarter and financial year ended March 31, 2021.",
            "news_id": "2b01dfa7-80f4-4260-9acf-f4cd66296a08",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e811672c-ea60-479d-9194-25a7c51d3aff.pdf",
            "news_date": "2021-05-29 14:48:45",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Held On May 29, 2021",
            "news_body": "The Company has informed the Exchange about the Outcome of the Board Meeting held on May 29, 2021.",
            "news_id": "9463a94d-23f7-42ad-8e29-7611e224854f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6bd5912f-44dc-4c5c-a585-2e5f1bcd700d.pdf",
            "news_date": "2021-05-29 14:46:16",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Earnings Conference Call for Q3FY21 and 9MFY21",
            "news_id": "a7843a34-8ee8-4d24-8343-5b2c0dae2352",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1a0a075a-e9de-4f36-a0df-921ef1accd5e.pdf",
            "news_date": "2021-02-21 22:09:54",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Earnings Presentation for the quarter and nine-months ended December 31, 2020",
            "news_id": "9c7a605c-d4bd-4f57-91e9-de42009ae9d2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3300969a-cd44-4cdb-85e0-9effa0fb47a7.pdf",
            "news_date": "2021-02-12 12:18:33",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results (Standalone & Consolidated) For The Quarter And Nine Months Ended December 31, 2020",
            "news_body": "Enclosed hereby are the Unaudited Financial Results (Standalone & Consolidated) for the quarter and nine-months ended December 31, 2020 along with the Limited Review report issued by B S R & Co. LLP, Statutory Auditors of the Company.<BR> <BR> The aforesaid financial results along with Limited review report are also being uploaded on the website of the Company, i.e. www.advancedenzymes.com. This is for your information and for public at large.",
            "news_id": "508d3b12-ff57-4424-b3d8-6336fee31dfb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=63e214d5-a22f-4f74-9a6f-16d4f410f5e3.pdf",
            "news_date": "2021-02-12 12:06:56",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting",
            "news_body": "With reference to the Board meeting notice dated February 02, 2021, we hereby inform that the Board of Directors in its meeting held on February 12, 2021 has inter-alia, approved the Unaudited Financial Results of the Company (Standalone & Consolidated) for the quarter and nine months ended December 31, 2020.<BR> <BR> In view of the aforesaid, we hereby enclose the following:<BR> Unaudited Financial Results (Standalone & Consolidated) for the quarter and nine months ended December 31, 2020 along with the Limited Review Report issued by B S R & Co. LLP, Statutory Auditors of the Company.<BR> Press Release and Earnings Presentation for the quarter and nine months ended December 31, 2020.<BR> Allotted 4,500 Equity Shares of face value of Rs. 2/- at an exercise price of Rs. 60/- per share pursuant to exercise of options under the Employees Stock Option Scheme, 2015.<BR> <BR> This is for your information and for public at large.",
            "news_id": "61ae5ad7-7dd3-4565-b986-ec2ec670ff9b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=90b7fca5-2dd2-4041-9325-2a53365a3a50.pdf",
            "news_date": "2021-02-12 12:03:00",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        }
    ]
}